CD155 expression and its correlation with clinicopathologic characteristics, angiogenesis, and prognosis in human cholangiocarcinoma

References

• AljiffryMWalshMJMolinariMAdvances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990–2009World J Gastroenterol200915344240426219750567
   PubMed Web of Science ®Google Scholar
• ValleJWBorbathIKhanSAHuguetFGruenbergerTArnoldDBiliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnn Oncol201627Suppl 5v28v3727664259
   PubMed Web of Science ®Google Scholar
• MansourJCAloiaTACraneCHHeimbachJKNaginoMVautheyJNHilar cholangiocarcinoma: expert consensus statementHPB (Oxford)201517869169926172136
   PubMed Web of Science ®Google Scholar
• WeberSMRiberoDO’ReillyEMKokudoNMiyazakiMPawlikTMIntrahepatic cholangiocarcinoma: expert consensus statementHPB (Oxford)201517866968026172134
   PubMed Web of Science ®Google Scholar
• TakaiYIrieKShimizuKSakisakaTIkedaWNectins and nectin-like molecules: roles in cell adhesion, migration, and polarizationCancer Sci200394865566712901789
   PubMed Web of Science ®Google Scholar
• KoikeSHorieHIseIThe poliovirus receptor protein is produced both as membrane-bound and secreted formsEMBO J1990910321732242170108
   PubMedGoogle Scholar
• MendelsohnCLWimmerERacanielloVRCellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamilyCell19895658558652538245
   PubMed Web of Science ®Google Scholar
• MassonDJarryABauryBOverexpression of the CD155 gene in human colorectal carcinomaGut200149223624011454801
   PubMed Web of Science ®Google Scholar
• GromeierMLachmannSRosenfeldMRGutinPHWimmerEInter-generic poliovirus recombinants for the treatment of malignant gliomaProc Natl Acad Sci U S A200097126803680810841575
   PubMed Web of Science ®Google Scholar
• NishiwadaSShoMYasudaSClinical significance of CD155 expression in human pancreatic cancerAnticancer Res20153542287229725862891
   PubMed Web of Science ®Google Scholar
• NakaiRManiwaYTanakaYOverexpression of Necl-5 correlates with unfavorable prognosis in patients with lung adenocarcinomaCancer Sci201010151326133020331633
   PubMed Web of Science ®Google Scholar
• KochJSteinleAWatzlCMandelboimOActivating natural cytotoxicity receptors of natural killer cells in cancer and infectionTrends Immunol201334418219123414611
   PubMed Web of Science ®Google Scholar
• ChanCJAndrewsDMMcLaughlinNMDNAM-1/CD155 interactions promote cytokine and NK cell-mediated suppression of poorly immunogenic melanoma metastasesJ Immunol2010184290291120008292
   PubMedGoogle Scholar
• Tahara-HanaokaSShibuyaKKaiHTumor rejection by the poliovirus receptor family ligands of the DNAM-1 (CD226) receptorBlood200610741491149616249389
   PubMed Web of Science ®Google Scholar
• SloanKEEustaceBKStewartJKCD155/PVR plays a key role in cell motility during tumor cell invasion and migrationBMC Cancer200447315471548
   PubMed Web of Science ®Google Scholar
• IkedaWKakunagaSTakekuniKNectin-like molecule-5/Tage4 enhances cell migration in an integrin-dependent, Nectin-3-independent mannerJ Biol Chem200427917180151802514871893
   PubMedGoogle Scholar
• KakunagaSIkedaWShingaiTEnhancement of serum- and platelet-derived growth factor-induced cell proliferation by Necl-5/Tage4/poliovirus receptor/CD155 through the Ras-Raf-MEK-ERK signalingJ Biol Chem200427935364193642515213219
   PubMedGoogle Scholar
• MorimotoKSatoh-YamaguchiKHamaguchiAInteraction of cancer cells with platelets mediated by Necl-5/poliovirus receptor enhances cancer cell metastasis to the lungsOncogene200827326427317637752
   PubMed Web of Science ®Google Scholar
• KinugasaMAmanoHSatomi-KobayashiSNecl-5/poliovirus receptor interacts with VEGFR2 and regulates VEGF-induced angio-genesisCirc Res2012110571672622282193
   PubMedGoogle Scholar
• EdgeSBComptonCCThe American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNMAnn Surg Oncol20101761471147420180029
   PubMed Web of Science ®Google Scholar
• ZhaiLLWuYHuangDWTangZGIncreased matrix metallopro-teinase-2 expression and reduced tissue factor pathway inhibitor-2 expression correlate with angiogenesis and early postoperative recurrence of pancreatic carcinomaAm J Transl Res20157112412242226807187
   PubMedGoogle Scholar
• WeidnerNSempleJPWelchWRFolkmanJTumor angiogenesis and metastasis – correlation in invasive breast carcinomaN Engl J Med1991324118
   PubMed Web of Science ®Google Scholar
• QuPHuangXZhouXLoss of CD155 expression predicts poor prognosis in hepatocellular carcinomaHistopathology201566570671425320021
   PubMedGoogle Scholar
• CarmelietPJainRKMolecular mechanisms and clinical applications of angiogenesisNature2011473734729830721593862
   PubMed Web of Science ®Google Scholar
• FolkmanJRole of angiogenesis in tumor growth and metastasisSemin Oncol2002296 Suppl 161518
   PubMed Web of Science ®Google Scholar
• HoebenALanduytBHighleyMSWildiersHVan OosteromATDe BruijnEAVascular endothelial growth factor and angiogenesisPharmacol Rev200456454958015602010
   PubMed Web of Science ®Google Scholar
• VeikkolaTKarkkainenMClaesson-WelshLAlitaloKRegulation of angiogenesis via vascular endothelial growth factor receptorsCancer Res200060220321210667560
   PubMed Web of Science ®Google Scholar
• MobiusCDemuthCAignerTEvaluation of VEGF A expression and microvascular density as prognostic factors in extrahepatic cholangiocarcinomaEur J Surg Oncol20073381025102917400419
   PubMed Web of Science ®Google Scholar
• YaoDFWuXHZhuYQuantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinomaHepatobiliary Pancreat Dis Int20054222022615908319
   PubMedGoogle Scholar
• AtsumiSMatsumineAToyodaHNiimiRIinoTSudoAPrognostic significance of CD155 mRNA expression in soft tissue sarcomasOncol Lett2013561771177623833639
   PubMedGoogle Scholar